Applied Research Center

Applied Research Center

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Applied Research Center is a private, revenue-generating clinical trial site services company that has executed over 400 trials since its founding in 2002. It serves as a critical operational partner for sponsors and CROs, facilitating drug and medical device development from early to post-marketing phases. The company differentiates itself through a patient-centric approach, offering participant compensation and access to novel therapies, while also expanding into wellness services. Its established track record in Arkansas positions it as a regional leader in decentralized clinical trial infrastructure.

Drug DeliveryMedical Devices

Technology Platform

Operational platform for clinical trial execution as a research site, including patient recruitment/retention, clinical operations, regulatory compliance, and integrated wellness services.

Opportunities

Growth in global clinical trial spending and the shift towards decentralized trials create demand for established, high-performing regional sites like ARC.
Its expansion into wellness services provides a complementary revenue stream and strengthens community engagement, potentially aiding patient recruitment for trials.

Risk Factors

Revenue is project-based and dependent on winning competitive site contracts from sponsors.
Geographic concentration in a single city limits scalability and increases exposure to local market risks.
Patient recruitment challenges and regulatory compliance issues could directly impact profitability and reputation.

Competitive Landscape

ARC competes with other independent clinical research sites, academic medical centers, and large site management organizations (SMOs). Its differentiation is based on its long-term regional presence, patient-centric approach, and integrated wellness offering. Competition is intensifying with the rise of virtual and hybrid trial models.